R‐ketorolac ameliorates cancer‐associated cachexia and prolongs survival of tumour‐bearing mice

R‐ketorolac ameliorates cancer‐associated cachexia and prolongs survival of tumour‐bearing mice

Abstract Background Cancer‐associated cachexia (CAC) is a debilitating syndrome associated with poor quality of life and reduced life expectancy of cancer patients. CAC is characterized by unintended body weight reduction due to muscle and adipose tissue loss. A major hallmark of CAC is systemic inf...

Full description

Bibliographic Details
Main Authors: Sophia E. Chrysostomou, Sandra Eder, Isabella Pototschnig, Anna‐Lena Mayer, Martina Derler, Marion Mussbacher, Silvia Schauer, Dongxu Zhang, Dongmei Yan, Gennie Liu, Gerald Hoefler, Thomas Weichhart, Paul W. Vesely, Lingbing Zhang, Martina Schweiger
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
cachexia
cancer
inflammation
ketorolac
Online Access:https://doi.org/10.1002/jcsm.13422

Internet

https://doi.org/10.1002/jcsm.13422

Similar Items